Quentec Asset Management Raised Oclaro (OCLR) Position By $9.11 Million, Nabriva Therapeutics AG Ads (NBRV) Sellers Decreased By 1.87% Their Shorts

June 20, 2017 - By Clifton Ray

Nabriva Therapeutics AG Ads (NASDAQ:NBRV) had a decrease of 1.87% in short interest. NBRV’s SI was 94,500 shares in June as released by FINRA. Its down 1.87% from 96,300 shares previously. With 18,300 avg volume, 5 days are for Nabriva Therapeutics AG Ads (NASDAQ:NBRV)’s short sellers to cover NBRV’s short positions. The SI to Nabriva Therapeutics AG Ads’s float is 1.4%. About 8,155 shares traded. Nabriva Therapeutics AG – ADR (NASDAQ:NBRV) has risen 15.31% since June 20, 2016 and is uptrending. It has underperformed by 1.39% the S&P500.

Quentec Asset Management Llc increased Oclaro Inc (OCLR) stake by 98.26% reported in 2016Q4 SEC filing. Quentec Asset Management Llc acquired 1.14 million shares as Oclaro Inc (OCLR)’s stock declined 22.87%. The Quentec Asset Management Llc holds 2.30 million shares with $20.56M value, up from 1.16 million last quarter. Oclaro Inc now has $1.60 billion valuation. It is 0.00% or $0 reaching $9.62 per share. It is down 92.74% since June 20, 2016 and is uptrending. It has outperformed by 76.04% the S&P500.

Investors sentiment decreased to 1.31 in Q4 2016. Its down 0.89, from 2.2 in 2016Q3. It fall, as 31 investors sold OCLR shares while 56 reduced holdings. 45 funds opened positions while 69 raised stakes. 102.68 million shares or 4.53% more from 98.22 million shares in 2016Q3 were reported. Alliancebernstein Lp invested in 2.02 million shares. Columbus Circle Invsts invested in 99,135 shares. Kopp Invest Advisors Ltd Co holds 8.17% in Oclaro, Inc. (NASDAQ:OCLR) or 864,536 shares. Minnesota-based Ameriprise Fincl Inc has invested 0.02% in Oclaro, Inc. (NASDAQ:OCLR). Blackrock invested in 12,968 shares or 0% of the stock. Nationwide Fund Advsr, a Pennsylvania-based fund reported 393,986 shares. Eam Invsts Ltd Liability Com stated it has 470,950 shares or 0.56% of all its holdings. Navellier & Assoc Inc holds 0.41% or 277,309 shares in its portfolio. Quentec Asset Mngmt Limited Liability Corp holds 2.29% or 2.30M shares. Hsbc Public Limited Com owns 32,640 shares. Concert Wealth invested in 0.05% or 27,300 shares. Moreover, Hood River Mngmt Ltd Liability has 1.32% invested in Oclaro, Inc. (NASDAQ:OCLR). Hanseatic Mngmt Services Incorporated, New Mexico-based fund reported 327 shares. 74,333 were accumulated by Blackrock Group. Raymond James And Assoc accumulated 0% or 44,113 shares.

Quentec Asset Management Llc decreased Ultratech Inc (NASDAQ:UTEK) stake by 203,606 shares to 373,263 valued at $8.95M in 2016Q4. It also reduced Skyworks Solutions Inc (Put) (NASDAQ:SWKS) stake by 70,900 shares and now owns 569,100 shares. Lattice Semiconductor Corp (NASDAQ:LSCC) was reduced too.

Among 10 analysts covering Oclaro Inc (NASDAQ:OCLR), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Oclaro Inc had 18 analyst reports since August 18, 2015 according to SRatingsIntel. Needham maintained Oclaro, Inc. (NASDAQ:OCLR) on Wednesday, November 4 with “Buy” rating. The rating was upgraded by Stifel Nicolaus to “Buy” on Thursday, October 22. The firm has “Outperform” rating given on Friday, December 18 by Barrington Research. The company was initiated on Monday, October 3 by Jefferies. M Partners maintained it with “Buy” rating and $11 target in Wednesday, November 2 report. The firm has “Buy” rating by Needham given on Wednesday, February 3. On Wednesday, November 2 the stock rating was maintained by Stifel Nicolaus with “Buy”. Needham maintained the shares of OCLR in report on Monday, October 31 with “Strong Buy” rating. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, September 6. The firm has “Hold” rating by Drexel Hamilton given on Friday, April 8.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: